| Financial Year |
March 31 2023 |
| Monetary Funds |
450,293,042.62 |
| Held-for-trading Financial Assets |
121,355,388.00 |
| Notes Receivable |
132,316,496.93 |
| Accounts Receivable |
725,182,268.65 |
| Advances to Suppliers |
77,475,898.85 |
| Other Receivables |
93,896,702.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
775,842,148.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
61,241,051.71 |
| Total Current Assets |
2,479,865,389.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
525,075,956.67 |
| Investment Properties |
74,408,703.02 |
| Fixed Assetes |
208,829,362.70 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,614,974.77 |
| R&D expenses |
-- |
| Goodwill |
28,592,865.03 |
| Long-Term Deferred and Prepaid Expenses |
2,749,157.20 |
| Deferred Income Tax Assets |
40,967,645.42 |
| Other Non-Current Assets |
88,727,837.28 |
| Sub-Total of Non-Current Assets |
1,079,926,585.06 |
| Total Assets |
3,559,791,974.47 |
| Short-Term Loans |
221,700,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
14,376,428.14 |
| Accounts Payable |
392,360,715.23 |
| Accounts Received In Advance |
681,750.00 |
| Employee Compensation Payable |
41,291,593.97 |
| Taxes Payable |
16,183,724.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
104,513,971.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
63,654,607.06 |
| Sub-Total of Current Liabilities |
1,318,026,626.55 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,631,960.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,230,060.97 |
| Total Liabilities |
1,335,256,687.52 |
| Paid-In Capital(Or Share Stock) |
436,800,000.00 |
| Capital Surplus |
200,368,584.42 |
| Surplus Reserve |
130,666,139.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,071,216,390.44 |
| Minority Stockholder's Interest |
383,966,364.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,840,568,922.15 |
| Owner's Equity（Stockholder's Equity） |
2,224,535,286.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,559,791,974.47 |
